Royalty Pharma Plc (RPRX) - Stock Price & Dividends

Royalty Pharma plc, listed on NASDAQ as RPRX, is a key player in the biopharmaceutical industry in the U.S. Their primary focus is acquiring biopharmaceutical royalties and supporting innovations within the sector. Apart from buying royalties, they actively identify, assess, and secure royalties for various biopharmaceutical treatments.

The company stands out for their collaborative approach, working closely with a diverse range of innovators from academic institutions, research hospitals, not-for-profits, as well as small to mid-cap biotechnology and pharmaceutical firms. This collaborative effort helps in expanding their portfolio and staying at the forefront of emerging trends in the industry.

With a robust portfolio, Royalty Pharma plc currently holds royalties for around 35 commercial products and has investments in 14 development-stage product candidates. Their focus areas include rare diseases, cancer, neuroscience, immunology, respiratory diseases, infectious diseases, hematology, and diabetes treatments, showcasing their commitment to diverse therapeutic fields.

The company has a rich history, being established in 1996 and headquartered in New York, New York. For more information, you can visit their website at https://www.royaltypharma.com.